Triple

T20301403
Position Surface form Disambiguated ID Type / Status
Subject Vaxzevria COVID-19 vaccine E505486 entity
Predicate hasAdverseEvent P24552 FINISHED
Object thrombosis with thrombocytopenia syndrome LITERAL FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: thrombosis with thrombocytopenia syndrome | Statement: [Vaxzevria COVID-19 vaccine, hasAdverseEvent, thrombosis with thrombocytopenia syndrome]
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: hasAdverseEvent
Context triple: [Vaxzevria COVID-19 vaccine, hasAdverseEvent, thrombosis with thrombocytopenia syndrome]
  • A. hasCommonAdverseEffect
    Indicates that two or more entities share at least one adverse effect that occurs in response to them.
  • B. commonAdverseReactions
    Indicates that the related entities are linked through adverse reactions or side effects that frequently occur in association with one another.
  • C. hasSeriousSideEffect chosen
    Indicates that an entity (such as a treatment, drug, or intervention) causes or is associated with a significant or severe adverse effect on another entity (typically a patient or biological system).
  • D. hadEvent
    Indicates that an entity experienced, hosted, or was associated with a specific event at some point in time.
  • E. hasContraindication
    Indicates that one entity (such as a treatment, drug, or procedure) should not be used or performed in the presence of another entity (such as a condition, factor, or co-medication) because it may cause harm or adverse effects.
  • F. None of above.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e0b4b8ab648190906e18538c250148 completed April 16, 2026, 10:06 a.m.
NER Named-entity recognition batch_69e6770c700c81909da247cef0d0f1eb completed April 20, 2026, 6:57 p.m.
PD Predicate disambiguation batch_69e55b21b09081909e46691b6f45a07f completed April 19, 2026, 10:45 p.m.
Created at: April 16, 2026, 11:17 a.m.